Kairos Ventures invests in ideas, patents, and businesses from the top universities and scientists.
Business Model: B2B
Revenue: $0
Employees: 0-0
Address: 9440 Santa Monica Blvd Ste 710
City: Beverly Hills
State: CA
Zip: 90210
Country: US
Kairos Ventures invests in ideas, patents, and businesses from the top universities and scientists. Kairos Venture Investments works to get science into the hands of applicable companies. Their team possesses an extraordinary passion to have a huge impact on our world through the creation of companies that will improve our lives and that of the generations that will follow. They aim to do this by backing the very best scientists, engineers and entrepreneurs and help them transform their knowledge, ideas and discoveries into viable businesses. They expect these companies to have a huge impact on the world and create significant returns for their shareholders.
Contact Phone:
+13102711866
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
1/2019 | Siege Pharmaceuticals | Venture Round | - |
12/2019 | Behavioral Signals | Series A | 7M |
1/2020 | PteroDynamics | Venture Round | - |
12/2019 | Pinpoint Therapeutics | Debt Financing | 0 |
6/2018 | PolyCera Membranes | Series A | 0 |
2/2018 | nFugue | Seed Round | - |
5/2017 | Holoclara | Seed Round | - |
8/2017 | NanoClear Technologies | Seed Round | - |
9/2017 | Transient Plasma Systems (TPS) | Seed Round | - |
6/2020 | Foldax | Series D | 0 |
6/2018 | Lifesprout | Seed Round | 6.5M |
3/2021 | AetherTouch | Seed Round | - |
7/2017 | Actinobac Biomed | Venture Round | 4.4M |
1/2018 | Keren Therapeutics | Venture Round | - |
8/2017 | Chimera Bioengineering | Seed Round | - |
11/2019 | MixComm | Series B | 8.6M |
3/2021 | Vivodyne | Venture Round | 2M |
6/2017 | 3D Bio Holdings | Seed Round | - |
4/2016 | Compellon | Series A | 6.7M |
3/2017 | Neuro-Bio | Series A | 3.2M |
1/2019 | Stoicheia | Seed Round | 5M |
1/2018 | Tanvas | Series A | - |
10/2017 | MixComm | Series A | - |
9/2017 | Sienza Energy | Seed Round | - |
11/2017 | Symbiotix Biotherapies | Venture Round | 5M |
9/2015 | Provivi | Series A | 7.5M |
2/2019 | Transient Plasma Systems, Inc. | Series A | 8.5M |
10/2019 | Provivi | Series C | 0 |
11/2017 | Provivi | Series B | 21M |
8/2017 | DEARhealth | Seed Round | - |
10/2016 | MemiRay | Series A | - |
4/2021 | TULU | Seed Round | 0 |
9/2017 | Repairogen | Seed Round | 1M |
12/2016 | Axial Biotherapeutics | Series A | 19.1M |
11/2019 | GuRu | Series A | 15M |
4/2016 | Applaud Medical | Series A | - |
9/2017 | GuRu | Seed Round | - |
9/2018 | Linnaeus Therapeutics | Series A | 4.4M |
9/2019 | Linnaeus | Series B | 12M |
3/2016 | Delpor | Series A | 1M |
7/2016 | KMLabs | Series A | 7.2M |
5/2019 | Xidas | Series A | 6M |
1/2021 | Novosteo | Series A | 0 |
12/2020 | Provivi | Series C | 0 |
9/2017 | Opera Therapeutics | Seed Round | - |
5/2019 | Actuate Therapeutics | Series B | 0 |
5/2020 | FGC Plasma Solutions | Venture Round | - |
11/2017 | 1200 Pharma | Seed Round | 6.2M |
1/2020 | Actinia | Venture Round | - |
3/2017 | Amorphology | Seed Round | - |
11/2016 | Axial Biotherapeutics | Series A | 19.5M |
1/2019 | NVasc | Venture Round | - |
11/2019 | Actuate Therapeutics | Series B | 0 |
4/2021 | TULU | Seed Round | 0 |
3/2021 | Vivodyne | Venture Round | 0 |
3/2021 | AetherTouch | Seed Round | - |
1/2021 | Novosteo | Series A | 0 |
12/2020 | Provivi | Series C | 0 |
6/2020 | Foldax | Series D | 0 |
5/2020 | FGC Plasma Solutions | Venture Round | - |
1/2020 | Actinia | Venture Round | - |
1/2020 | PteroDynamics | Venture Round | - |
12/2019 | Pinpoint Therapeutics | Debt Financing | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|